Literature DB >> 24366588

Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery.

Davide Capodanno1, Dominick J Angiolillo.   

Abstract

Entities:  

Keywords:  purinergic P2Y receptor antagonists; surgical procedures, operative; thrombosis

Mesh：

Substances：

Year:  2013        PMID： 24366588     DOI： 10.1161/CIRCULATIONAHA.113.003675

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  23 in total

1.  Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.

Authors:  Daisuke Izumi; Masatoshi Miyahara; Naoki Fujimoto; Shusuke Fukuoka; Masataka Sakai; Kaoru Dohi; Masaaki Ito
Journal:  Heart Vessels       Date:  2015-09-03       Impact factor: 2.037

2.  A pharmacist's guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.

Authors:  Margaret L Ackman; Claudia Bucci; Michael Callaghan; Heather Kertland; Chantal Pharand; Patrick Robertson; William Semchuk
Journal:  Can Pharm J (Ott)       Date:  2015-03

3.  Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease.

Authors:  Reema George; Anugya Bhatt; Jayakumari Narayani; Jissa Vinoda Thulaseedharan; Harikrishnan Sivadasanpillai; Jaganmohan A Tharakan
Journal:  Mol Cell Biochem       Date:  2016-07-12       Impact factor: 3.396

4.  Clopidogrel Therapy in Patients with Cardiovascular Disease Undergoing Transurethral Resection of the Prostate: A Step Towards Individualization.

Authors:  Petros Tzimas; Maria Tsoumani; Dimitrios Giannakis; Kallirroi Kalantzi; Anastasios Petrou; Vasileios Chantzichristos; Nikolaos Sofikitis; Georgios Papadopoulos; Haralampos Milionis; Alexandros Tselepis
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 5.  Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.

Authors:  Davide Cao; Rishi Chandiramani; Davide Capodanno; Jeffrey S Berger; Matthew A Levin; Mary T Hawn; Dominick J Angiolillo; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2020-08-05       Impact factor: 32.419

Review 6.  Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy.

Authors:  Houssein A Youness; Jean Keddissi; Ilya Berim; Ahmed Awab
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

7.  Coronary Angiography and Revascularization Prior to Noncardiac Surgery.

Authors:  Joshua Schulman-Marcus; Raymond A Pashun; Dmitriy N Feldman; Rajesh V Swaminathan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

8.  Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.

Authors:  Sarah C Oltmann; Amal Y Alhefdhi; Mohammad H Rajaei; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2016-05-02       Impact factor: 5.344

9.  Bariatric Surgery in Patients on Chronic Anticoagulation Therapy.

Authors:  Gautam Sharma; Zubaidah Nor Hanipah; Ali Aminian; Suriya Punchai; Emre Bucak; Philip R Schauer; Stacy A Brethauer
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 10.  Novel antiplatelet agents in acute coronary syndrome.

Authors:  Francesco Franchi; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2014-10-07       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.